Familial predisposition to breast cancer in a British population: Implications for prevention

European Journal of Cancer

Volumn 36, Issue 6, 2000, Pages 773-779

  Pharoah, P D P ^a   Lipscombe, J M ^a   Redman, K L ^b   Day, N E ^c   Easton, D F ^b   Ponder, B A J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Univ of C   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast cancer; Family history; Prevention; Risk

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER MORTALITY; CANCER RISK; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MORBIDITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RELATIVE;

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; ENGLAND; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; PREVALENCE; REGISTRIES; RISK ASSESSMENT;

EID: 0034034101     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00023-X     Document Type: Article

References (20)

1. Health of the Nation Key Areas Handbook: Cancers. 1993;Department of Health, London.
2. Kelsey J.L., Gammon M.D., John E.M. Reproductive factors and breast cancer. Epidemiol. Rev. 15:1993;36-47.
3. Fisher B., Costantino J.P., Wickerham D.L.et al. Tamoxifen for prevention of breast cancer. report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J. Natl. Cancer Inst. 90:1998;1371-1388.
4. Powles T., Eeles R., Ashley S.et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 352:1998;98-101.
5. Veronesi U., Maisonneuve P., Costa A.et al. Prevention of breast cancer with tamoxifen. preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study Lancet. 352:1998;93-97.
6. Cummings S.R., Eckert S., Krueger K.A.et al. The effect of raloxifene on risk of breast cancer in postmenopausal women. results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation JAMA. 281:1999;2189-2197.
7. Kerlikowske K., Grady D., Rubin S.M., Sandrock C., Ernster V.L. Efficacy of screening mammography. a meta-analysis JAMA. 273:1995;149-154.
8. Fletcher S.W., Black W., Harris R., Rimer B.K., Shapiro S. Report of the international workshop of screening for breast cancer. J. Natl. Cancer Inst. 85:1993;1644-1656.
9. Feig S.A. Increased benefit from shorter screening mammography intervals for women ages 40-49 years. Cancer. 80:1997;2035-2039.
10. Pharoah P.D.P., Day N.E., Duffy S., Easton D.F., Ponder B.A.J. Family history and the risk of breast cancer. a systematic review and meta-analysis Int. J. Cancer. 71:1997;800-809.
11. Andrieu N., Clavel F., Auquier A.et al. Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors. J. Clin. Epidemiol. 46:1993;973-980.
12. Colditz G.A., Willett W.C., Hunter D.J.et al. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. JAMA. 270:1993;338-343.
13. Peto J., Easton D.F., Matthews F.E., Ford D., Swerdlow A.J. Cancer mortality in relatives of women with breast cancer. the OPCS study Int. J. Cancer. 65:1996;273-283.
14. Tulinius H., Day N.E., Bjarnason O.et al. Familial breast cancer in Iceland. Int. J. Cancer. 29:1982;365-371.
15. Adami H.O., Hansen J., Jung B., Rimsten A. Characteristics of familial breast cancer in Sweden. absence of relation to age and unilateral versus bilateral disease Cancer. 48:1981;1688-1695.
16. Bain C., Speizer F.E., Rosner B., Belanger C., Hennekens C.H. Family history of breast cancer as a risk indicator for the disease. Am. J. Epidemiol. 111:1980;301-308.
17. Sattin R.W., Rubin G.L., Webster L.A.et al. Family history and the risk of breast cancer. JAMA. 253:1985;1908-1913.
18. Breslow N.E., Day N.E. Statistical methods in cancer research volume 2 - the analysis of cohort studies. 1980;International Agency for Research on Cancer, Lyon.
19. Miettinen O.S. Proportion of disease caused or prevented by a given, exposure, trait or intervention. Am. J. Epidemiol. 99:1974;325.
20. Kerber R.A., Slattery M.L. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am. J. Epidemiol. 146:1997;244-248.